Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 1672 | 54.2 |
09:50 ET | 400 | 53.74 |
09:52 ET | 300 | 53.67 |
09:57 ET | 200 | 53.89 |
10:06 ET | 100 | 53.77 |
10:10 ET | 200 | 53.588 |
10:14 ET | 500 | 53.565 |
10:15 ET | 650 | 53.565 |
10:17 ET | 3283 | 53.51 |
10:19 ET | 300 | 53.52 |
10:21 ET | 300 | 53.32 |
10:24 ET | 400 | 53.4 |
10:26 ET | 200 | 53.49 |
10:28 ET | 100 | 53.64 |
10:33 ET | 200 | 53.44 |
10:35 ET | 1454 | 53.318 |
10:37 ET | 1228 | 53.67 |
10:39 ET | 100 | 53.705 |
10:44 ET | 100 | 53.66 |
10:46 ET | 318 | 53.705 |
10:53 ET | 300 | 53.625 |
10:57 ET | 100 | 53.645 |
11:00 ET | 200 | 53.59 |
11:02 ET | 200 | 53.6 |
11:04 ET | 100 | 53.72 |
11:08 ET | 100 | 53.7 |
11:09 ET | 5334 | 53.66 |
11:11 ET | 100 | 53.66 |
11:18 ET | 700 | 53.67 |
11:20 ET | 403 | 53.63 |
11:22 ET | 2273 | 53.56 |
11:24 ET | 100 | 53.6 |
11:26 ET | 100 | 53.54 |
11:27 ET | 100 | 53.6025 |
11:29 ET | 1401 | 53.61 |
11:31 ET | 1801 | 53.56 |
11:33 ET | 600 | 53.665 |
11:36 ET | 200 | 53.53 |
11:38 ET | 400 | 53.565 |
11:40 ET | 367 | 53.6 |
11:42 ET | 900 | 53.63 |
11:44 ET | 300 | 53.58 |
11:45 ET | 2181 | 53.44 |
11:49 ET | 100 | 53.425 |
11:51 ET | 600 | 53.34 |
11:54 ET | 803 | 53.39 |
11:56 ET | 200 | 53.36 |
11:58 ET | 314 | 53.44 |
12:00 ET | 1200 | 53.6 |
12:02 ET | 200 | 53.6 |
12:03 ET | 666 | 53.68 |
12:05 ET | 500 | 53.65 |
12:07 ET | 2200 | 53.7 |
12:12 ET | 2152 | 53.61 |
12:14 ET | 300 | 53.595 |
12:16 ET | 200 | 53.59 |
12:18 ET | 100 | 53.59 |
12:20 ET | 100 | 53.54 |
12:21 ET | 100 | 53.58 |
12:23 ET | 230 | 53.675 |
12:25 ET | 1100 | 53.68 |
12:27 ET | 100 | 53.675 |
12:30 ET | 100 | 53.67 |
12:32 ET | 700 | 53.655 |
12:36 ET | 600 | 53.625 |
12:38 ET | 1100 | 53.645 |
12:41 ET | 500 | 53.745 |
12:43 ET | 300 | 53.66 |
12:45 ET | 905 | 53.71 |
12:48 ET | 600 | 53.585 |
12:50 ET | 935 | 53.555 |
12:52 ET | 400 | 53.51 |
12:56 ET | 100 | 53.33 |
12:59 ET | 200 | 53.305 |
01:01 ET | 400 | 53.2 |
01:03 ET | 200 | 53.04 |
01:06 ET | 100 | 53.007 |
01:10 ET | 1452 | 53.075 |
01:12 ET | 481 | 53.075 |
01:14 ET | 900 | 53.19 |
01:26 ET | 300 | 53.17 |
01:28 ET | 300 | 53.13 |
01:32 ET | 300 | 53.09 |
01:33 ET | 800 | 53.025 |
01:35 ET | 500 | 53.07 |
01:39 ET | 100 | 53.08 |
01:42 ET | 1326 | 53.05 |
01:44 ET | 800 | 53.11 |
01:48 ET | 100 | 53.11 |
01:50 ET | 400 | 52.99 |
01:53 ET | 100 | 52.92 |
01:55 ET | 1916 | 52.93 |
02:02 ET | 215 | 52.88 |
02:06 ET | 200 | 52.96 |
02:08 ET | 200 | 52.9397 |
02:11 ET | 500 | 53 |
02:13 ET | 500 | 52.88 |
02:15 ET | 300 | 52.875 |
02:18 ET | 500 | 52.93 |
02:20 ET | 200 | 52.95 |
02:22 ET | 300 | 52.95 |
02:24 ET | 100 | 52.93 |
02:26 ET | 300 | 52.9 |
02:27 ET | 325 | 52.84 |
02:29 ET | 300 | 52.87 |
02:31 ET | 400 | 52.98 |
02:33 ET | 200 | 53.06 |
02:36 ET | 100 | 53.12 |
02:38 ET | 781 | 53.05 |
02:40 ET | 100 | 53 |
02:42 ET | 300 | 52.975 |
02:45 ET | 200 | 53.07 |
02:51 ET | 300 | 53.11 |
02:54 ET | 300 | 53.15 |
02:56 ET | 200 | 53.08 |
02:58 ET | 200 | 53.07 |
03:00 ET | 467 | 53.13 |
03:02 ET | 300 | 53.09 |
03:03 ET | 338 | 53.175 |
03:05 ET | 300 | 53.17 |
03:07 ET | 100 | 53.15 |
03:12 ET | 1000 | 53.08 |
03:14 ET | 1200 | 53.18 |
03:16 ET | 318 | 53.175 |
03:18 ET | 400 | 53.22 |
03:20 ET | 100 | 53.2 |
03:21 ET | 100 | 53.17 |
03:23 ET | 500 | 53.1 |
03:27 ET | 1024 | 53.08 |
03:30 ET | 225 | 53.065 |
03:32 ET | 309 | 53.09 |
03:34 ET | 2317 | 53.14 |
03:36 ET | 215 | 53.07 |
03:38 ET | 2079 | 53.04 |
03:39 ET | 600 | 53.085 |
03:41 ET | 700 | 53 |
03:43 ET | 300 | 52.96 |
03:45 ET | 5200 | 53.15 |
03:48 ET | 1765 | 53.16 |
03:50 ET | 500 | 53.23 |
03:52 ET | 2388 | 53.265 |
03:54 ET | 3184 | 53.085 |
03:56 ET | 4259 | 52.99 |
03:57 ET | 3894 | 53.03 |
03:59 ET | 106949 | 53.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.3B | -14.1x | --- |
Dyne Therapeutics Inc | 4.7B | -12.7x | --- |
Biohaven Ltd | 3.9B | -4.4x | --- |
Immunovant Inc | 4.8B | -16.4x | --- |
BridgeBio Pharma Inc | 4.8B | -9.4x | --- |
Iovance Biotherapeutics Inc | 3.6B | -6.9x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | 3,118.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.